Evidence map›Paper›PMID 32801819›Full record

ReviewDiabetes, metabolic syndrome and obesity : targets and therapy2020

A Review of Research Progress on Glycemic Variability and Gestational Diabetes.

Wenshu Yu, Na Wu, Ling Li, Hong OuYang, Meichen Qian, Haitao Shen

Open access · goldAbstract readReview
In one paragraph

Review in Diabetes, metabolic syndrome and obesity : targets and therapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 45 citations in OpenAlex.

  1. Trial
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Progress in Research on Biomarkers of Gestational Diabetes Mellitus and Preeclampsia.Diabetes, metabolic syndrome and obesity : targets and therapy · 2023
    Review
  14. Article
  15. Glycemic Variability in Early Pregnancy May Predict a Subsequent Diagnosis of Gestational Diabetes.Diabetes, metabolic syndrome and obesity : targets and therapy · 2022
    Article
  16. Article
  17. Article
  18. Research Progress on the Experimental Animal Model of Gestational Diabetes Mellitus.Diabetes, metabolic syndrome and obesity : targets and therapy · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Wenshu YuDepartment of Endocrinology, Shengjing Hospital of China Medical University, Shenyang, People' s Republic of China.
Na WuDepartment of Endocrinology, Shengjing Hospital of China Medical University, Shenyang, People' s Republic of China.
Ling LiDepartment of Endocrinology, Shengjing Hospital of China Medical University, Shenyang, People' s Republic of China.
Hong OuYangDepartment of Endocrinology, Shengjing Hospital of China Medical University, Shenyang, People' s Republic of China.
Meichen QianDepartment of Endocrinology, Shengjing Hospital of China Medical University, Shenyang, People' s Republic of China.
Haitao ShenDepartment of Emergency Medicine, Shengjing Hospital of China Medical University, Shenyang, People's Republic of China.
China Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gestational diabetes mellitus (GDM) is associated with many adverse obstetric outcomes and neonatal outcomes, including preeclampsia, Cesarean section, and macrosomia. Active screening and early diabetes control can reduce the occurrence of adverse outcomes. Glycosylated hemoglobin (HbA1c) only reflects average blood glucose levels, but not glycemic variability (GV). Studies have shown that GV can cause a series of adverse reactions, and good control of GV can reduce the incidence of adverse pregnancy outcomes in patients with GDM. In order to provide clinicians with a better basis for diagnosis and treatment, this study reviewed the measurement, evaluation, and control of GV, the importance of GV for patients with GDM, and correlations between GV and maternal and neonatal outcomes.

Indexed as

continuous glucose monitoringgestational diabetes mellitusglycemic variabilityoutcomesself-monitoring of blood glucose

Identifiers

PMID32801819
PMCPMC7414929
OpenAlexW3047527842

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.